Ftse Mib
35.104,09
0,47%
DAX
20.390,45
0,20%
S&P 500
5.909,03
-1,11%
NASDAQ
19.489,68
-1,89%
Bitcoin
95.676,97
-1,26%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ KALA BIO Inc (KALA) KALA BIO Inc (KALA) Notizie

KALA

KALA BIO (KALA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KALA
DataOraFonteTitoloSimboloCompagnia
08/01/202502:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
03/01/202513:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KALAKALA BIO Inc
31/12/202422:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KALAKALA BIO Inc
30/12/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
30/12/202414:00GlobeNewswire Inc.KALA BIO Announces $10,750,000 Private PlacementNASDAQ:KALAKALA BIO Inc
27/11/202414:00GlobeNewswire Inc.KALA BIO to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
14/11/202422:49Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KALAKALA BIO Inc
12/11/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
12/11/202414:00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
06/09/202422:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:KALAKALA BIO Inc
08/08/202414:00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:KALAKALA BIO Inc
06/08/202414:00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
01/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KALAKALA BIO Inc
31/07/202422:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KALAKALA BIO Inc
25/07/202422:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KALAKALA BIO Inc
17/07/202423:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
09/07/202402:54Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KALAKALA BIO Inc
27/06/202414:00GlobeNewswire Inc.KALA BIO Announces $12,500,000 Private PlacementNASDAQ:KALAKALA BIO Inc
30/05/202422:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KALAKALA BIO Inc
29/05/202414:00GlobeNewswire Inc.KALA BIO to Present at Jefferies Global Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
14/05/202422:05GlobeNewswire Inc.KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
29/03/202413:00GlobeNewswire Inc.KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
26/02/202414:00GlobeNewswire Inc.KALA BIO to Present at TD Cowen 44th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
14/02/202419:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KALAKALA BIO Inc
06/02/202414:00GlobeNewswire Inc.KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:KALAKALA BIO Inc
19/01/202422:01GlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
13/11/202314:00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
18/10/202322:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KALAKALA BIO Inc
05/09/202314:00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:KALAKALA BIO Inc
04/08/202314:00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KALA

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ILTY
Illimity Bank
BIT
STLAM
Stellantis NV
BIT
BFF
BFF Bank
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
IF
Banca IFIS
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network